Period Ending | Mar 30, 2012 | Dec 30, 2011 | Sep 29, 2011 | Jun 29, 2011 |
---|
Total Revenue
|
5,503,000
|
5,964,000
|
5,583,000
|
5,614,000
| Cost of Revenue | 3,795,000 | 4,041,000 | 3,755,000 | 3,737,000 | |
Gross Profit
|
1,708,000
|
1,923,000
|
1,828,000
|
1,877,000
| |
|
Operating Expenses |
|
Research Development | 173,000 | 179,000 | 183,000 | 175,000 |
|
Selling General and Administrative | 1,123,000 | 1,097,000 | 1,195,000 | 1,223,000 |
|
Non Recurring | 17,000 | 61,000 | (4,000) | (9,000) |
|
Others | 82,000 | 139,000 | 87,000 | 87,000 |
|
|
|
Total Operating Expenses | 1,395,000 | 1,476,000 | 1,461,000 | 1,476,000 | | |
Operating Income or Loss
|
313,000
|
447,000
|
367,000
|
401,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 313,000 | 447,000 | 367,000 | 401,000 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 313,000 | 447,000 | 367,000 | 401,000 |
|
Income Tax Expense | 77,000 | 102,000 | 81,000 | 108,000 |
|
Minority Interest | (7,000) | (8,000) | (9,000) | (8,000) |
|
|
|
Net Income From Continuing Ops | 269,000 | 375,000 | 320,000 | 319,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
269,000
|
375,000
|
320,000
|
319,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
269,000
|
375,000
|
320,000
|
319,000
|
|